GHO Capital, a healthcare investment firm, agreed to invest in Sapio Sciences, a lab informatics platform company. Financial terms were not disclosed. "As lab workflows become increasingly complex and the volume of data increases, the management and interrogation of that data becomes even more vital. Over the last eighteen years, Sapio has built a uniquely flexible, scalable, unified and easy-to-use informatics platform developed specifically to address the deficiencies of current processes. We are proud to have GHO partner with us to support our next transformational steps as a company," Kevin Cramer, Sapio Chief Scientist and CEO.